The publisher Frontiers has retracted at least a dozen papers in the last month, after announcing an “extensive internal investigation” into “potentially falsified research.”
Here’s an example of a notice, this one from Frontiers in Endocrinology for “Overexpression of microRNA-216a-3p Accelerates the Inflammatory Response in Cardiomyocytes in Type 2 Diabetes Mellitus by Targeting IFN-α2,” which was originally published in November 2020:
Continue reading Frontiers retracts a dozen papers, many more expected